Citadel Advisors - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is and the CUSIP is 72940R902. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$5,000
-50.0%
2,500
-39.0%
0.00%
Q2 2015$10,000
-60.0%
4,100
-53.9%
0.00%
Q1 2015$25,000
+1150.0%
8,900
+1012.5%
0.00%
Q4 2014$2,000
+100.0%
800
+166.7%
0.00%
Q3 2014$1,000
-91.7%
300
-92.3%
0.00%
Q2 2014$12,000
-80.3%
3,900
-76.5%
0.00%
Q1 2014$61,000
+177.3%
16,600
+167.7%
0.00%
Q4 2013$22,000
+15.8%
6,200
+10.7%
0.00%
Q3 2013$19,000
-34.5%
5,600
-41.7%
0.00%
Q2 2013$29,0009,6000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 97,200$297,0000.01%
Citadel Advisors 9,600$29,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders